Skip to content

Head to head

Elite iQ vs GentleMax Pro (2026)

Compare purchase costs, running costs and the evidence behind each device.

Read the comparison overview
Purchase cost
The catalog lists $69,950 (dealer-described unused 2019 unit with three handpieces) for GentleMax Pro. No new-price range is on file for Elite iQ. Check the source notes and request current quotes.
Technology
Elite iQ: Alexandrite. GentleMax Pro: Nd:YAG.
Practice fit
Both are listed under dual-wavelength platform. Check each model’s US regulatory status and labeled indications for your intended use.

Dual-wavelength platform

View full device profile →

Dual-wavelength platform

View full device profile →

Price comparison

New price range

Cynosure Elite iQ
Not published
Candela GentleMax Pro
$69,950 (dealer-described unused 2019 unit with three handpieces)Reported source: Dealer quote · Oct 7, 2026

Used price reference

Cynosure Elite iQ
$45k–$70kSource not documented
Candela GentleMax Pro
28975-67000 (core cluster 37700-57500)Reported source: Used listing · Aug 30, 2026

Payback calculator

Cynosure Elite iQ
View ROI calculator
Candela GentleMax Pro
View ROI calculator

Next step

Cynosure Elite iQ
Candela GentleMax Pro

Explore this model’s specs and owner reviews. For new-equipment inquiries, browse current models.

Browse current models

Supplies & running costs

Supplies & restrictions

Cynosure Elite iQ

Supply pricing is not documented with a dated source yet. Request an itemized supply quote.

View running-cost details
Candela GentleMax Pro
Read supply costs & requirements

Budget for DCD cryogen and applicable replacement parts. Current US manufacturer prices for cryogen, distance gauges and flashlamps, and cryogen usage for a specified treatment, have not been verified here. The catalog therefore does not establish a per-treatment cost.

Dealer quote · Aug 30, 2026

Supply restrictions: no published lock — no electronic gating documented

View running-cost details

FDA status & indications

FDA status & indication

Cynosure Elite iQ
FDA record cited — see scopeK193426, K240396

Record scope: K193426 names Elite iQ. K240396 separately names Elite iQ PRO (M122K1); it should not be assigned indiscriminately to an original Elite iQ. Indications are wavelength-specific and Skintel measures melanin to set a test-spot starting fluence, not a guarantee of safe settings.

Read FDA indication wording
“755nm: The Elite iQ laser is indicated for stable long-term or permanent hair reduction. Permanent hair reduction is defined as long-term stable reduction in the number of hairs regrowing when measured at 6, 9 or 12 months after the completion of a treatment regime. It is used for skin types (Fitzpatrick I-VI) including tanned skin. It is also indicated for the treatment of vascular lesions, benign pigmented lesions, and wrinkles. 1064nm: The Elite iQ laser is intended for the coagulation and hemostasis of benign vascular lesions such as, but not limited to, port wine stains, hemangiomas, warts, telangiectasia, rosacea, venous lakes, leg veins, spider veins and poikiloderma of Civatte; and treatment of benign cutaneous lesions such as warts, scars, striae and psoriasis. The laser is also intended for the treatment of benign pigmented lesions such as, but not limited to, lentigines (age spots), solar lentigines (sunspots), cafe au lait macules, seborrheic keratoses, nevi, chloasma, 755 nm: The Cynosure Elite+ Laser is indicated for stable long-term, or permanent hair reduction. Permanent hair reduction is defined as long-term stable reduction in the number of hairs regrowting when measured 6, 9, or 12 months after the completion of a treatment regime. It is used for all skin types (Fitzpatrick I-VI) including tanned skin. It is also indicated for the treatment of vascular lesions, benign pigmented lesions, and wrinkles. 1064 nm: The Cynosure Elite+ Laser is intended for the coagulation and hemostasis of benign vascular lesions such as, but not limited to, port wine stains, hemangiomas, warts, telangectasia, rosacea, venus lake, leg veins, spider veins and poikiloderma of civatte; and treatment of benign cutaneous lesions such as warts, scars, striae and psoriasis. The laser is also intended for the treatment of benign pigmented lesions such as, but not limited to, lentigos (age spots), solar lentigos (sun spots), cafe au lait macules, seborrheic 755mn laser: Temporary hair reduction. Stable long-term or permanent hair reduction through selective targeting of melanin in hair follicles. Permanent hair reduction is defined as the long-term, stable reduction in the number of hairs regrowing when measured at 6,9, and 12 months after the completion of a treatment regime. On all skin types (Fitzpatrick I - VI) including tanned skin. Treatment of benign pigmented lesions. Treatment of wrinkles.”
Candela GentleMax Pro
FDA record cited — see scopeK140122, K201111

Record scope: Family clearance: K140122 (CANDELA GENTLEMAX FAMILY, Candela Corp., decision 9 May 2014) and K201111 (GentleMax Pro Plus, Candela, decision 26 May 2020, family). Checked 4 Sep 2026.

Read FDA indication wording
“The GentleMAX Family of Laser Systems is indicated for the following at the specified wavelength: 7S5nm Temporary hair reduction. Stable long-term or permanent reduction through selective targeting of melanin in hair follicles. Permanent hair reduction isdefined as long-term stable reduction in the number of hairs regrowing after a treatment regime. Permanent hair reduction is defined as the long-term, stable reduction in the number of hairs regrowing when measured at 6, 9, and 12 months after the completion of a treatment regime. On all skin types (Fitzpatrick [- VI) including tanned skin. Treatment of benign pigmented lesions. Treatment of wrinkles. The photocoagulation of dermatological vascular lesions (such as pant-wine stains, hemangiomas, telangiectasias) 1064nm Removal of unwanted hair, for stable long term or permanent hair reduction and for treatment of PFB. Permanent hair reduction isdefined as the long-term, stable reduction in the number of hairs regrowing when measured at 6, 9, and 12 months after the completion of a treatment regime. The lasers are indicated on all skin types Fitzpatrick I-VI including tanned skin. Photocoagulation and hemostasis of pigmented and vascular lesions such as but not limited to port wine stains, hemangioma, warts, telangiectasia, rosacea, venus lake, leg veins and spider veins. Coagulation and hemostasis of soft tissue. Benign pigmented lesions such as, but not limited to, lentigos (age spots), solar lentigos (sun spots), cafd au ]ait macules, seborrheic keratosis, nevi, chloasma, verrucae, skin tags, keratosis, tattoos (significant reduction in the intensity of black and/or blue-black tattoos) and plaques. The laser is indicated for pigmented lesions to reduce lesion size, for patients with lesions that would potentially benefit from aggressive treatment, and for patients with lesions that have not responded to other laser treatments. Reduction of red pigmentation in hypertrophic and keloid scars where vascularity is an integral part of the scar. Treatment of wrinkles. 1064nm Temporary increase of clear nail in patients with onychomycosis (e.g., derniatophytes, Trichophyton rubrum and T. mentagrophytes, and for yeast Candida Albicans, etc.)”

Which chains run each

Chain adoption

Cynosure Elite iQ
2 recorded pairings
Candela GentleMax Pro
3 recorded pairings

Chains using it

Cynosure Elite iQ
  • SEV Laser(Confirmed)
  • Foxy Box Laser + Wax Bar(Confirmed)
Candela GentleMax Pro
  • Milan Laser Hair Removal(Confirmed)
  • SEV Laser(Confirmed)
  • Body Details(Confirmed)

Approved reviews

Cynosure Elite iQ
0
Candela GentleMax Pro
0

Specs and platform

Manufacturer

Cynosure Elite iQ
Cynosure
Candela GentleMax Pro
Candela

Built by (OEM)

Cynosure Elite iQ
Cynosure LLC
Candela GentleMax Pro
Candela Corporation

Category

Cynosure Elite iQ
Dual-wavelength platform
Candela GentleMax Pro
Dual-wavelength platform

Technology

Cynosure Elite iQ
755/1064nm + Skintel melanin reader (Alexandrite)
Candela GentleMax Pro
755nm alex + 1064nm Nd:YAG (Nd:YAG)

Launch year

Cynosure Elite iQ
2020
Candela GentleMax Pro
2013

Status

Cynosure Elite iQ
Current
Candela GentleMax Pro
Discontinued

Manufacturing relationship evidence

Cynosure Elite iQ
No separate manufacturing-relationship record linked.
Candela GentleMax Pro
No separate manufacturing-relationship record linked.

Current alternatives

Current catalog models in related categories. Confirm availability and configuration with the supplier.

No current alternatives identified in the catalog yet. Browse current models

Device and company names are trademarks of their respective owners. The Aesthetic Index is not affiliated with or endorsed by any manufacturer, distributor or lender named here, except as disclosed. Price figures are references, not current offers. Check each device’s source notes. Not medical, legal or regulatory advice.